Savara
Savara Inc is an American clinical-stage biopharmaceutical enterprise headquartered in Austin, Texas. The company specializes in the research, development, and commercialization of innovative pulmonary therapeutics for rare respiratory diseases, anchored by its proprietary drug development pipeline. Principal revenue is currently earned through research collaborations, grant funding, and capital financing arrangements as clinical pipelines advance. Savara Inc is publicly listed on the Nasdaq Stock Market.
2 of the funds FundTelligence covers report a position in Savara.
- Legal name
- Savara Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 2
Funds holding Savara
- Swedbank Robur Healthcare — Swedbank · 0.3 % (full portfolio disclosed, October 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.06 % (full portfolio disclosed, October 2026)